Furthermore, TRIM27 promotes IL-6-induced STAT3 activation by mediating ubiquitination of protein inhibitor of activated STAT3, thereby aggravating psoriasis (a chronic inflammatory disease that predominantly affects the skin and joints), colitis, and colitis-associated cancer (33, 34). Here, STAT3 is linked to colitis.